Portfolio Modeling, Analysis and Management by Divakar Chitturi A ...
Pregnancy and NCD Committee (2018-2021)...Hema Divakar- Co-chair, India Anil Kapur - India David...
Transcript of Pregnancy and NCD Committee (2018-2021)...Hema Divakar- Co-chair, India Anil Kapur - India David...
the Global Voice for Women’s Health
Pregnancy and NCD Committee
(2018-2021)
Prof. Moshe Hod
Chair , FIGO Pregnancy and NCD Committee
Tel-Aviv , Israel
Maternal & Offspring Health
FIGO Pregnancy & NCD Committee In 2018 FIGO merged the HIP and Nutrition WG ;
FIGO PREGNANCY & NCD CommitteeThe key focus areas :
Prediction and Prevention – Pregnancy Complications
Life Course Approach to NCD Prevention.
Pregnancy will be in the center with specific endpoints for intervention
- Pre – pregnancy (already with NCD)
- Pregnancy – as early as possible but focusing on the 1st Trimester.
- Post- Pregnancy for mother and offspring with links to major
Health organizations: Neonatologists, Pediatricians, Family Physicians and
others related to morbidities (Diabetes, Cardiovascular, other).
Leading towards Prevention of NCD for Mother and Offspring
HIPMoshe Hod Anil Kapur
Hema Divakar
HAP1&2Liona Poon
PostPartum
Eyal Sheiner
NutritionPONIM. Hanson
F. McAuliffe
Fetal GrowthNir Melamed
Ahmet Baschat
FIGO Pregnancy & NCD Guidelines
Moshe Hod - Chair , Israel
Mark Hanson- Co-chair, UK
Hema Divakar- Co-chair, India
Anil Kapur - India
David McIntyre – Australia
Mary D'Alton – SMFM (US)
Anne Beatrice Kihara- Kenya, (Africa)
Ronald Ma – (HKG), China
Fionnuala Mcauliffe, Ireland
Florence DIP 2019
Post-Partum Management
Delivery
NeonatalInsulin
resistance
Childhoodobesity
Early metabolic syndrome
PCOSAdulthood
obesity
NCD’s - DM, Obesity, HT, CVD, Mental…
Pre-Conception Management
Pregnancy ComplicationsGDM/PET/IPL/IUGR/IUFD
Pregnancy Complications(GDM/PET/IPL/IUGR/IUFD)
The Life Cycle approach
PREGNANCY is the Window of Opportunity
1st Trimester 2nd & 3rd Trimester
Abnormal Intrauterine Environment
Programming & Imprinting
Maternal Health
Maternal Health
Offspring Health
FM 3 Generations
1
2
3
Treatment, Management
Follow up
Prediction Prevention
Ca we prevent it ?
The Botero Metabolic Family
When & How ?